Back

Baseline characteristics and 6-month echocardiographic assessment of chamber size in the REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure Trial: the first HFpEF device trial.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Heart failure Heart failure, other ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Frank E Silvestry

University of Pennsylvania, Philadelphia (United States of America)

48 More presentations in this session

Presentation thumbnail
Vitamin D deficiency increases risk of heart failure: prospective results from the moli-sani study
Doctor S. Costanzo (Rome, IT)
Abstract
Presentation thumbnail
Association between renal resistance index and one year worsening of renal function in chronic heart failure outpatients
Associate Professor M. Iacoviello (Foggia, IT)
Abstract Slides
Presentation thumbnail
The neuro-mechanical unloading therapy for acute myocardial ischemia markedly reduces infarct size and prevents heart failure in the long term
Doctor T. Arimura (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
SGLT1 participates in cardiac remodeling in pressure-overload-induced cardiomyopathy.
Doctor N. Matsushita (Yahabacho, JP)
Abstract
Presentation thumbnail
Signature of both endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction
Professor A. Berezin (Salzburg, AT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Heart failure

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources